Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7193635 | 0.77 | CES2 (0.31) | CES2CES1 | |
| SCHEMBL4707298 | 0.76 | DUT (0.31) | — | |
| SCHEMBL3867444 | 0.70 | ACHE (0.44) | ACHETDP1CYP3A4TSHRLMNA | |
| SCHEMBL7862064 | 0.69 | ACHE (0.42) | ACHETDP1CYP3A4TSHRLMNA | |
| SCHEMBL3873557 | 0.67 | ACHE (0.46) | ACHETDP1CYP3A4TSHRLMNA | |
| SCHEMBL4705071 | 0.67 | KDM4E (0.31) | LMNAALDH1A1GAA | |
| SCHEMBL475824 | 0.67 | LMNA (0.48) | ACHETDP1LMNAMEN1KMT2A | |
| SCHEMBL3402601 | 0.67 | TDP1 (0.35) | ACHETDP1CYP3A4TSHRLMNA | |
| SCHEMBL13870133 | 0.65 | ACHE (0.46) | ACHETDP1TSHRLMNAMEN1 | |
| SCHEMBL3867374 | 0.65 | ACHE (0.38) | ACHETDP1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1368384-B1 | MANUFACTURE OF CONJUGATED DIENE POLYMERS USING AN IRON-BASED CATALYST COMPOSITION | BRIDGESTONE CORP (JP) | 2008-08-20 | — | — | EP | disclosed |
| EP-1368384-A1 | MANUFACTURE OF CONJUGATED DIENE POLYMERS USING AN IRON-BASED CATALYST COMPOSITION | Bridgestone Corporation (JP) | 2003-12-10 | — | — | EP | disclosed |
| US-6627712-B2 | Reaction product of an iron-containing compound, a silyl phosphonate, and an organoaluminum compound to polymerize 1,3-butadiene into syndiotactic 1,2-polybutadiene | BRIDGESTONE CORPORATION (JP) | 2003-09-30 | — | — | US | disclosed |
| WO-2002100910-A1 | MOLYBDENUM-BASED CATALYST COMPOSITION FOR PRODUCING SYNDIOTACTIC 1,2-POLYBUTADIENE | BRIDGESTONE CORPORATION (JP) | 2002-12-19 | — | — | WO | disclosed |
| US-20020156210-A1 | Manufacture of conjugated diene polymers by using an iron-based catalyst composition | BRIDGESTONE CORP. | 2002-10-24 | — | — | US | disclosed |
| WO-2002081082-A1 | IRON-BASED CATALYST COMPOSITION FOR PRODUCING OLIGOMERS OF CONJUGATED DIENES | BRIDGESTONE CORPORATION (JP) | 2002-10-17 | — | — | WO | disclosed |
| WO-2002066525-A1 | CHROMIUM-BASED CATALYST COMPOSITION | BRIDGESTONE CORPORATION (JP) | 2002-08-29 | — | — | WO | disclosed |
| WO-2002066523-A1 | MANUFACTURE OF CONJUGATED DIENE POLYMERS USING AN IRON-BASED CATALYST COMPOSITION | BRIDGESTONE CORPORATION (JP) | 2002-08-29 | — | — | WO | disclosed |
| US-20020115558-A1 | CHROMIUM-BASED CATALYST COMPOSITION FOR PRODUCING CONJUGATED DIENE POLYMERS | BRIDGESTONE CORP. | 2002-08-22 | — | — | US | disclosed |
| US-6433237-B1 | USING COORDINATION CATALYST | BRIDGESTONE CORPORATION (JP) | 2002-08-13 | — | — | US | disclosed |